CryoLife, Bayer Corp. deal

Bayer let lapse its six-month option to exclusively negotiate a worldwide license for CRYL's FibRx fibrin-based bioadhesive technology. Bayer paid $250,000 for the option. FibRx is a biodegradable sur...